521 related articles for article (PubMed ID: 10470095)
41. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
42. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
43. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line.
McMaster ML; Gessler M; Stanbridge EJ; Weissman BE
Cell Growth Differ; 1995 Dec; 6(12):1609-17. PubMed ID: 9019166
[TBL] [Abstract][Full Text] [Related]
44. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.
Li RS; Law GL; Seifert RA; Romaniuk PJ; Morris DR
Exp Cell Res; 1999 Feb; 247(1):257-66. PubMed ID: 10047468
[TBL] [Abstract][Full Text] [Related]
45. [The Wilms' tumor suppressor gene WT1].
Akiyama T
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1612-7. PubMed ID: 9279088
[No Abstract] [Full Text] [Related]
46. Transcriptional activation of c-myc proto-oncogene by WT1 protein.
Han Y; San-Marina S; Liu J; Minden MD
Oncogene; 2004 Sep; 23(41):6933-41. PubMed ID: 15286719
[TBL] [Abstract][Full Text] [Related]
47. Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1.
Kim JM; Hong Y; Semba K; Kim S
Biochem Biophys Res Commun; 2000 Jan; 267(1):59-63. PubMed ID: 10623574
[TBL] [Abstract][Full Text] [Related]
48. Pax-2, kidney development, and oncogenesis.
Dressler GR
Med Pediatr Oncol; 1996 Nov; 27(5):440-4. PubMed ID: 8827071
[TBL] [Abstract][Full Text] [Related]
49. [Wilms' tumors and malformation complexes].
Hata J; Fukuzawa R; Takata A; Kikuchi H
Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
[TBL] [Abstract][Full Text] [Related]
50. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
[TBL] [Abstract][Full Text] [Related]
51. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
[TBL] [Abstract][Full Text] [Related]
52. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
Rauscher FJ
FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
[TBL] [Abstract][Full Text] [Related]
53. Tissue-specific regulation of the WT1 locus.
Hewitt JA; Kessler PM; Campbell CE; Williams BR
Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
[TBL] [Abstract][Full Text] [Related]
54. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
55. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
[TBL] [Abstract][Full Text] [Related]
56. Regulation of the rat p75 neurotrophin receptor promoter by GC element binding proteins.
Poukka H; Kallio PJ; Jänne OA; Palvimo JJ
Biochem Biophys Res Commun; 1996 Dec; 229(2):565-70. PubMed ID: 8954938
[TBL] [Abstract][Full Text] [Related]
57. WT1: what has the last decade told us?
Little M; Holmes G; Walsh P
Bioessays; 1999 Mar; 21(3):191-202. PubMed ID: 10333728
[TBL] [Abstract][Full Text] [Related]
58. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
59. Sequence of the WT1 upstream region including the Wit-1 gene.
Gessler M; Bruns GA
Genomics; 1993 Aug; 17(2):499-501. PubMed ID: 8406502
[TBL] [Abstract][Full Text] [Related]
60. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation.
Malik KT; Wallace JI; Ivins SM; Brown KW
Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
